Mariner’s Mirum Pharmaceuticals MIRM Stock Holding History

Mariner’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,464	Closed	-$201K	–	3608
2025 Q1	$201K	Buy	+4,464	New	+$210K	﹤0.01%	3009

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mariner's MIRM Position: Q2 2025 in Review

Mariner sold out of Mirum Pharmaceuticals (MIRM) in Q2 2025, closing a stake of 4,464 shares — an estimated $201K sold.

Mariner first reported a position in MIRM in Q1 2025 and held it in 1 quarter. The position peaked at $201K in Q1 2025. 214 funds tracked by Wall St. Rank hold MIRM as of Q2 2025.

Mariner reported no remaining Mirum Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Mariner sold 4,464 Mirum Pharmaceuticals shares in Q2 2025, an estimated $201K.
Mariner first reported a position in Mirum Pharmaceuticals in Q1 2025 and held it in 1 quarter.
Mariner's Mirum Pharmaceuticals position peaked at $201K in Q1 2025.
214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2025.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.